| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/15/2011 | US20110224223 MTOR Modulators and Uses Thereof |
| 09/15/2011 | US20110224206 Triazole compounds that modulate hsp90 activity |
| 09/15/2011 | US20110224185 Compounds and compositions as modulators of gpr119 activity |
| 09/15/2011 | US20110224183 16, 17-carbocyclic condensed steroid compounds having slective estrogenic activity |
| 09/15/2011 | US20110224155 Modulation of chemosensory receptors and ligands associated therewith |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224145 Neuromodulators and Methods of Use |
| 09/15/2011 | US20110224133 Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110224095 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 09/15/2011 | US20110223684 Detection of specific nitrated markers |
| 09/15/2011 | US20110223670 Ets2 and mesp1 generate cardiac progenitors from fibroblasts |
| 09/15/2011 | US20110223669 Method of efficiently establishing induced pluripotent stem cells |
| 09/15/2011 | US20110223668 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
| 09/15/2011 | US20110223667 Metabolic engineering of lipid metabolism by improving fatty acid binding and transport |
| 09/15/2011 | US20110223666 Cytoplasm exposure additive and method for exposing particles delivered into cell to cytoplasm from endocytic vesicles in intact cell |
| 09/15/2011 | US20110223665 ENHANCEMENT OF siRNA SILENCING ACTIVITY USING UNIVERSAL BASES OR MISMATCHES IN THE SENSE STRAND |
| 09/15/2011 | US20110223664 Materials and methods of introducing genetic material into living cells |
| 09/15/2011 | US20110223663 Composition for preserving platelets and method of using the same |
| 09/15/2011 | US20110223662 Composition for preserving platelets and method of using the same |
| 09/15/2011 | US20110223661 Inhibitors of stat3 |
| 09/15/2011 | US20110223660 Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising wnt signaling pathway activators |
| 09/15/2011 | US20110223659 Compositions And Methods For Detecting Severe Acute Respiratory Syndrome Coronavirus |
| 09/15/2011 | US20110223658 Monoclonal antibodies with enhanced adcc function |
| 09/15/2011 | US20110223657 Trp/his exchange and kynurenin induced trp transport |
| 09/15/2011 | US20110223635 Method and Composition for Controlling Gene Expression |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223609 Gene defects and mutant ALK kinase in human solid tumors |
| 09/15/2011 | US20110223257 Releasable fusogenic lipids for nucleic acids delivery systems |
| 09/15/2011 | US20110223240 Compounds for reversing and inhibiting protein aggregation, and methods for making and using them |
| 09/15/2011 | US20110223209 Oxygen delivering scaffold for tissue engineering |
| 09/15/2011 | US20110223205 Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
| 09/15/2011 | US20110223188 Targeted costimulatory polypeptides and methods of use to treat cancer |
| 09/15/2011 | US20110223185 Chimeric hepatitis c virus antigens for eliciting an immune response |
| 09/15/2011 | US20110223182 Monoclonal antibodies for treatment of cancer |
| 09/15/2011 | US20110223178 Antibodies That Specifically Bind to Chemokine Beta-4 |
| 09/15/2011 | US20110223176 Basigin binding proteins |
| 09/15/2011 | US20110223173 Botulinum Neurotoxin A Receptor and the Use Thereof |
| 09/15/2011 | US20110223165 Humanized C-Kit Antibody |
| 09/15/2011 | US20110223163 Monoclonal antibodies that react with the capsule of bacillus anthracis |
| 09/15/2011 | US20110223160 Compositions and methods relating to glucagon receptor antibodies |
| 09/15/2011 | US20110223155 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/15/2011 | US20110223153 Modified silk films containing glycerol |
| 09/15/2011 | US20110223147 Lysosomal targeting peptides and uses thereof |
| 09/15/2011 | US20110223146 Methods for preparation and use of marrow infiltratng lymphoctyes (mils) |
| 09/15/2011 | US20110223144 Creation of a Biological Atrioventricular Bypass to Compensate for Atrioventricular Block |
| 09/15/2011 | US20110223143 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 09/15/2011 | US20110223142 Methods and compositions for soft tissue repair |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223140 Method for differentiation into retinal cells from stem cells |
| 09/15/2011 | US20110223139 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| 09/15/2011 | US20110223138 Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223128 Regulation of microvasculature occlusion |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223107 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/15/2011 | CA2792933A1 Enterobacter sp. 638 and methods of use thereof |
| 09/15/2011 | CA2792910A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | CA2792802A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 09/14/2011 | EP2365089A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 09/14/2011 | EP2365086A1 Novel omega-3 fatty acid desaturase family members and uses thereof |
| 09/14/2011 | EP2365085A1 Growth hormone fusion protein |
| 09/14/2011 | EP2365082A1 BVDV virus-like particles |
| 09/14/2011 | EP2365081A2 13 Transmembrane protein expressed in prostate cancer |
| 09/14/2011 | EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe) |
| 09/14/2011 | EP2365074A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/14/2011 | EP2365073A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/14/2011 | EP2365071A1 Transformed soybean plant which stores vaccine, and use thereof |
| 09/14/2011 | EP2365062A1 Rapid production of monoclonal antibodies |
| 09/14/2011 | EP2365061A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 09/14/2011 | EP2365060A1 Method for controlling pH, osmolality and dissolved carbon dioxide levels in a mammalian cell culture process to enhance cell viability and biologic product yield |
| 09/14/2011 | EP2365006A2 Novel anti-IGF-IR antibodies and uses thereof |
| 09/14/2011 | EP2365005A2 Novel anti-IGF-IR antibodies and uses thereof |
| 09/14/2011 | EP2365001A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 09/14/2011 | EP2364999A2 Dual-specific ligand and its use |
| 09/14/2011 | EP2364997A2 Polypeptide variants with altered effector function |
| 09/14/2011 | EP2364728A1 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 09/14/2011 | EP2364710A1 Therapeutic use of D-allose |
| 09/14/2011 | EP2301580A9 Container holding anti-VEGF antibodies |
| 09/14/2011 | EP1882737B1 Process for production of l-serine derivative and enzyme used in the process |
| 09/14/2011 | EP1829960B1 Method for production of plant cell having chromosome loss |
| 09/14/2011 | EP1761635B1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 09/14/2011 | EP1691854B1 Hydrogel providing cell-specific ingrowth |
| 09/14/2011 | EP1599575B1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/14/2011 | EP1541674B9 Primary cultured adipocytes for gene therapy |
| 09/14/2011 | EP1441766B1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 09/14/2011 | EP1405906B1 Schwann cells originating from bone marrow stromal cells |
| 09/14/2011 | EP1349955B1 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 09/14/2011 | EP1312669B1 Cultured epidermal cell sheet, laminated cultured skin sheet and process for producing the same |
| 09/14/2011 | EP1262555B1 Protein hollow nano particles, transporter with the use of the same and method of introducing substance into cells |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | EP1027440B2 Inhibitor protein of the wnt signal pathway |
| 09/14/2011 | CN1891826B Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 09/14/2011 | CN1882608B Isolated photoprotein mtclytin, and use thereof |
| 09/14/2011 | CN1845988B Method for immunotherapy of tumors |
| 09/14/2011 | CN1561345B Antibodies to VLA-1 |
| 09/14/2011 | CN102186971A Treatment of stroke using isolated placental cells |
| 09/14/2011 | CN102186970A Ischemic tissue cell therapy |
| 09/14/2011 | CN102186969A Methods for preparing human skin substitutes from human pluripotent stem cells |
| 09/14/2011 | CN102186968A Methods of obtaining cell populations from adipose tissue |